New Delhi [India], July 25 (ANI): The Central Drugs Standard Control Organisation (CDSCO) has suspended the import licenses of at least 19 firms for their respective COVID-19 test kits after USFDA removed the manufacturer from their list of the product of serology test kits for coronavirus.
New Delhi [India], July 24 (ANI): The Central Drugs Standard Control Organisation (CDSCO) has suspended the import license of Mumbai-based company--Transasia Bio-Medicals which is providing COVID-19 IgG ELISA kit.
New Delhi [India], May 1 (ANI): About 60 Indian firms have got approval from the Central Drugs Standard Control Organisation (CDSCO) for RT-PCR testing kits for COVID-19. Out of the 60 companies, five firms got approval for indigenously manufactured kits and 55 others for imported kits.
New Delhi [India], April 20 (ANI): The Indian Council of Medical Research (ICMR) has received 99 applications for participation in "Randomized controlled study to assess the safety and efficacy of convalescent plasma to limit COVID-19 associated complications".
New Delhi [India], April 18 (ANI): The Central Drugs Standard Control Organisation (CDSCO) has given a green signal to interested institutes to conduct the clinical trial with convalescent plasma in COVID-19 patients, as per the protocol developed by Indian Council of Medical Research (ICMR)
New Delhi [India] April 29 (ANI/NewsVoir): Medical Technology Association of India (MTaI), which represents leading research-based medical technology companies having a large footprint in manufacturing, R&D and healthcare training in India, today said that creation of a separate verti
New Delhi [India], Nov 16 (ANI): As Industry associations prepare to submit a detailed representation of Medical Device Industry to the Central Drugs Standard Control Organisation (CDSCO) and Ministry of Health and Family Welfare it has been a winding exercise for last six months involving a